Journal of Clinical Investigation, 2026
Lipoprotein(a)-Associated Proteomic Signature Predicts Cardiovascular Disease in Young Adults

Goonewardena S., Yao S., Jurga T. et al.

Clinical and Translational Science, 2026
GlycA as an Effect Modifier of Protein–Mortality Associations: A Prospective Cohort Study

Wang X., Qiao Z., Tao C. et al.

British Journal of Dermatology, 2026
A clinically actionable stratification of bullous pemphigoid using a disease activity score reveals a targetable inflammatory endotype

Cao Z., Kong S., Ye J. et al.

Communications Biology, 2026
Maternal-infant immune signatures in infants at risk for SARS-CoV-2-associated neurodevelopmental disorders

Fajardo-Martinez V., Ferreira F., Salem G. et al.

Canadian Journal of Cardiology, 2026
Clinical and community factors' correlation with NT-proBNP in First Nations: a cross-sectional analysis of the CAHHM-FN cohort

Marchand M., Labiba Z., Schulze K. et al.

PLOS One, 2026
Serum proteomic changes in atopic dermatitis patients treated with cyclosporine

Olydam J., Litman T., Nijsten T. et al.

Blood Journal, 2026
IFNγ Drives Long-Term Bone Marrow Niche Dysfunction Following Doxorubicin-Based Chemotherapy

Li X., .Aguilar-Navarro A., Nader M. et al.

Psychoneuroendocrinology, 2026
Investigating the association of a selected inflammatory protein panel with suicide attempts in the PsyCourse Study: A pilot study

Oraki Kohshour M., Budde M., Solomon P. et al.

The American Journal of Clinical Nutrition, 2026
Plasma proteomics enhances heart failure risk prediction among individuals with type 2 diabetes: a prospective cohort study

Yu H., Zhang J., Qian F. et al.

Environment International, 2026
Association between urban heat island and type 2 diabetes risk: genetic and proteomic insights

Ren J., Sun X., Zhang Z. et al.

Clinical Cancer Research, 2026
Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial

Li Z., Izadmehr S., Hoffman-Censits J. et al.

Brain, 2026
Machine learning model based on plasma proteomics for the identification of Parkinson’s disease

Adewale B., Chia R., Moaddel R. et al.

Biology of Sex Differences, 2026
Sex differences in proteomic response to ischemic stroke

McLouth C., Hazelwood H., Frank J. et al.

Translational Psychiatry, 2026
Divergence of C4A and C4B in first-episode psychosis: Insights from CSF and plasma immune profiling

Arjmand S., Chaudhary M., Piehl F. et al.

Journal of Experimental & Clinical Cancer Research, 2026
Liquid biopsy reveals the immune status and protein profiles linked to CTC burden and clinical outcomes in metastatic breast cancer

Kurma K., Bardol T., Mollevi C. et al.

Cell Genomics, 2026
Interferon-related inflammaging links epigenetic age acceleration to multimorbidity

Liu Z., Ziogas A., Zhang Y. et al.

JNCI: Journal of the National Cancer Institute, 2026
Premenopausal and postmenopausal obesity and endometrial cancer risk: circulating biomarkers of inflammation, insulin resistance, and sex hormones as mediators

Wang S., Viallon V., Biessy C. et al.

European Journal of Pharmacology, 2026
Chrysin attenuates tramadol-driven renal dysfunction via regulation of RNA networks, antioxidant pathways, and ketogenic metabolism

Öz M., Kandemir ?., Özdemir S. et al.

Genome Medicine, 2026
Maternal-prenatal gut microbiome-systemic metabolome perturbations and TH2-skewed immunity link to offspring gut microbiome disruption and atopic dermatitis susceptibility

Ng D., Yap G., Tay C. et al.

ERJ Open Research, 2026
Systemic and local lymph node inflammation at disease onset in sarcoidosis patients

Robert M., Boizeau L., Cappy P. et al.